RLFTY — MindMaze Therapeutics Holding SA
—
OTC ·
Health Care ·
Pharmaceuticals ·
CIK 1854078 ·
Switzerland
Last close
$1.73
Market Cap
$264.43M
52W High
$2.40
52W Low
$0.27
ADV30
32
Next earnings
—
No quarterly fundamentals indexed for this ticker.
Annual Trend (SEC EDGAR, last 2y)
Revenues vs Net Income (last 2y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 642,000 | -10,515,000 | -9,906,000 | 51,530,000 | 13,189,000 | — | -7,208,000 |
| Dec 2024 | 0 | -2,000 | -1,000 | 93,000 | 7,000 | — | -3,000 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| PRLD | Prelude Therapeutics Inc | $265.51M | $4.09 | — |
| NVCT | Nuvectis Pharma, Inc. | $267.91M | $10.10 | — |
| TRDA | Entrada Therapeutics, Inc. | $260.10M | $6.70 | — |
| ALXO | ALX ONCOLOGY HOLDINGS INC | $259.71M | $1.93 | — |
| FHTX | Foghorn Therapeutics Inc. | $256.58M | $4.37 | — |
News headlines (Yahoo Finance, 1h cache)
MindMaze Therapeutics Announces CHF 8.0 Million Strategic Equity Financing
2026-05-26 05:50 · Yahoo
MindMaze Therapeutics and Vibra Healthcare Sign Definitive Channel Partnership Agreement to Scale Advanced Neurotherapeutics Across the U.S.
2026-05-12 05:25 · Yahoo
MindMaze Therapeutics Announces Initiation of Coverage by Baader Bank
2026-03-19 06:35 · Yahoo
MindMaze Therapeutics Appoints HealthTech Veteran Zach Henderson as CEO to Accelerate Global Commercial Scale
2026-03-12 07:44 · Yahoo
MindMaze Therapeutics Provides Corporate Update and Publishes March 2026 Investor Presentation
2026-03-03 07:45 · Yahoo
MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics
2025-12-23 06:20 · Yahoo
Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze Therapeutics
2025-12-15 06:20 · Yahoo
Relief Therapeutics Shareholders Approve Business Combination with NeuroX
2025-11-14 17:40 · Yahoo
Relief Therapeutics Announces Positive Results from Pivotal Bioequivalence Study of RLF-OD032
2025-10-29 06:20 · Yahoo
Relief Therapeutics Publishes 2025 Half-Year Report
2025-08-14 05:20 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.